Editor's Note High-level disinfection (HLD) fails to reliably eliminate harmful microbes from flexible endoscopes in real-world healthcare settings, according to a review of endoscope processing effectiveness published April 8 in the American Journal of Infection Control. The review highlights routine breaches in cleaning protocols and links contaminated endoscopes to numerous…

Read More

Editor's Note Researchers have developed a fully dissolvable, needle-injectable pacemaker that regulates heart rhythms without requiring surgical removal. As detailed in an April 2 article in Scientific American, the miniature device—just millimeters in size—can deliver electrical stimulation for days to weeks before safely breaking down in the body, potentially reducing…

Read More

Editor's Note Pulse oximeters may overestimate blood oxygen levels in critically ill patients with darker skin tones, according to a March 30 article in HCP Live. The article focuses on the EquiOx study, conducted at the Zuckerberg San Francisco General Hospital between 2022 and 2024. Presented at the American College…

Read More

Editor's Note Arthroplasty implants may release metals that accumulate in the central nervous system (CNS), potentially contributing to neurotoxic effects, according to a study published March 28 in JAMA Network Open. Researchers found that patients with large joint replacements had significantly higher levels of cobalt, chromium, titanium, niobium, and zirconium…

Read More

Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…

Read More

Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…

Read More

Editor's Note Baxter Healthcare Corporation has issued a letter to affected customers recommending certain Spectrum infusion pumps be removed from where they are used or sold, according to a March 5 early alert from the US Food and Drug Administration (FDA). The FDA notice concerns the Sigma Spectrum Infusion System…

Read More

Health systems are fundamentally capital intensive. They are regulated; depend on highly educated, high-cost employees; and operate under complex reimbursement structures. Investing in new technologies and infrastructure upgrades is imperative to keeping up with the latest medical advances. But what happens when capital funds are insufficient or no longer available?…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…

Read More

Editor’s Note The US Food and Drug Administration (FDA) has designated Boston Scientific Corporation’s recall of Accolade Pacemaker devices a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s February 21 announcement, the recall was motivated by a manufacturing issue that could…

Read More